VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Monday, December 29, 2025
Stock Comparison
Alphabet Inc. vs Novo Nordisk A/S
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Alphabet Inc.
GOOGL · The Nasdaq Stock Market
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Alphabet Inc.'s moat claims, evidence, and risks.
View GOOGL analysisNovo Nordisk A/S
NOVOB · Nasdaq Copenhagen
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Novo Nordisk A/S's moat claims, evidence, and risks.
View NOVOB analysisComparison highlights
- Moat score gap: Alphabet Inc. leads (86 / 100 vs 85 / 100 for Novo Nordisk A/S).
- Segment focus: Alphabet Inc. has 6 segments (56.6% in Google Search & other (Advertising)); Novo Nordisk A/S has 3 segments (71.1% in Diabetes care).
- Primary market structure: Quasi-Monopoly vs Oligopoly. Pricing power: Strong vs Moderate.
- Moat breadth: Alphabet Inc. has 10 moat types across 4 domains; Novo Nordisk A/S has 5 across 3.
Primary market context
Alphabet Inc.
Google Search & other (Advertising)
Search advertising (intent-based digital ads)
Global
Advertisers (SMB to enterprise)
Ad platform / publisher
56.6%
Novo Nordisk A/S
Diabetes care
Diabetes pharmaceuticals (GLP-1 for type 2 diabetes, insulin, and related therapies)
Global
Payers/providers and patients (via wholesalers/pharmacies/hospitals)
Originator pharma (R&D, regulatory, manufacturing, commercialization)
71.1%
Side-by-side metrics
Moat coverage
Shared moat types
No overlap yet.
Alphabet Inc. strengths
Novo Nordisk A/S strengths
Segment mix
Alphabet Inc. segments
Full profile >Google Search & other (Advertising)
Quasi-Monopoly
YouTube (Advertising)
Oligopoly
Google Network (Advertising)
Competitive
Google Subscriptions, Platforms & Devices
Quasi-Monopoly
Google Cloud
Oligopoly
Other Bets
Competitive
Novo Nordisk A/S segments
Full profile >Diabetes care
Oligopoly
Obesity care
Duopoly
Rare disease
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.